Search Page

1

Cite

Share

Lactylation-driven METTL3-mediated RNA m⁶A modification promotes immunosuppression of tumor-infiltrating myeloid cells.

Xiong J, He J, Zhu J, Pan J, Liao W, Ye H, Wang H, Song Y, Du Y, Cui B, Xue M, Zheng W, Kong X, Jiang K, Ding K, Lai L, Wang Q. Xiong J, et al. Among authors: kong x. Mol Cell. 2022 May 5;82(9):1660-1677.e10. doi: 10.1016/j.molcel.2022.02.033. Epub 2022 Mar 22. Mol Cell. 2022. PMID: 35320754

Cite

Share

2

Cite

Share

Targeting Immune Cells in the Tumor Microenvironment of HCC: New Opportunities and Challenges.

Hao X, Sun G, Zhang Y, Kong X, Rong D, Song J, Tang W, Wang X. Hao X, et al. Among authors: kong x. Front Cell Dev Biol. 2021 Nov 12;9:775462. doi: 10.3389/fcell.2021.775462. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34869376 Free PMC article. Review.

Cite

Share

3

Cite

Share

CST6 protein and peptides inhibit breast cancer bone metastasis by suppressing CTSB activity and osteoclastogenesis.

Li X, Liang Y, Lian C, Peng F, Xiao Y, He Y, Ma C, Wang Y, Zhang P, Deng Y, Su Y, Luo C, Kong X, Yang Q, Liu T, Hu G. Li X, et al. Among authors: kong x. Theranostics. 2021 Oct 11;11(20):9821-9832. doi: 10.7150/thno.62187. eCollection 2021. Theranostics. 2021. PMID: 34815788 Free PMC article.

Cite

Share

4

Cite

Share

PIL transcription factors directly interact with SPLs and repress tillering/branching in plants.

Zhang L, He G, Li Y, Yang Z, Liu T, Xie X, Kong X, Sun J. Zhang L, et al. Among authors: kong x. New Phytol. 2022 Feb;233(3):1414-1425. doi: 10.1111/nph.17872. Epub 2021 Dec 3. New Phytol. 2022. PMID: 34800046

Cite

Share

5

Cite

Share

Epigenetic Modifications and Therapy in Uveitis.

Zou Y, Li JJ, Xue W, Kong X, Duan H, Li Y, Wei L. Zou Y, et al. Among authors: kong x. Front Cell Dev Biol. 2021 Nov 18;9:758240. doi: 10.3389/fcell.2021.758240. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34869347 Free PMC article. Review.

Cite

Share

6

Cite

Share

Bacterial Ghosts-Based Vaccine and Drug Delivery Systems.

Chen H, Ji H, Kong X, Lei P, Yang Q, Wu W, Jin L, Sun D. Chen H, et al. Among authors: kong x. Pharmaceutics. 2021 Nov 8;13(11):1892. doi: 10.3390/pharmaceutics13111892. Pharmaceutics. 2021. PMID: 34834306 Free PMC article. Review.

Cite

Share

7

Cite

Share

Efficacy and safety of camrelizumab plus apatinib during the perioperative period in resectable hepatocellular carcinoma: a single-arm, open label, phase II clinical trial.

Xia Y, Tang W, Qian X, Li X, Cheng F, Wang K, Zhang F, Zhang C, Li D, Song J, Zhang H, Zhao J, Yao A, Wu X, Wu C, Ji G, Liu X, Zhu F, Qin L, Xiao X, Deng Z, Kong X, Li S, Yu Y, Xi W, Deng W, Qi C, Liu H, Pu L, Wang P, Wang X. Xia Y, et al. Among authors: kong x. J Immunother Cancer. 2022 Apr;10(4):e004656. doi: 10.1136/jitc-2022-004656. J Immunother Cancer. 2022. PMID: 35379737 Free PMC article. Clinical Trial.

Cite

Share

8

Cite

Share

C-C motif chemokine ligand 5 confines liver regeneration by down-regulating reparative macrophage-derived hepatocyte growth factor in a forkhead box O 3a-dependent manner.

Huang M, Jiao J, Cai H, Zhang Y, Xia Y, Lin J, Shang Z, Qian Y, Wang F, Wu H, Kong X, Gu J. Huang M, et al. Among authors: kong x. Hepatology. 2022 Mar 15. doi: 10.1002/hep.32458. Online ahead of print. Hepatology. 2022. PMID: 35288960

Cite

Share

9

Cite

Share

Melatonin Participates in Selenium-Enhanced Cold Tolerance of Cucumber Seedlings.

Yang N, Sun K, Wang X, Wang K, Kong X, Gao J, Wen D. Yang N, et al. Among authors: kong x. Front Plant Sci. 2021 Dec 22;12:786043. doi: 10.3389/fpls.2021.786043. eCollection 2021. Front Plant Sci. 2021. PMID: 35003171 Free PMC article.

Cite

Share

10

Cite

Share

[Clinical phenotype and genetic analysis of MECP2 duplication syndrome].

Chen D, Wang L, Hou Y, Shi P, Qin G, Kong X. Chen D, et al. Among authors: kong x. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2021 Dec 10;38(12):1190-1193. doi: 10.3760/cma.j.cn511374-20200603-00407. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2021. PMID: 34839504 Chinese.

Cite

Share